Certified by Founder Lodge
Roivant Sciences
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $8,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technolog
Lokavant
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Furientis | $5,000,000 | (May 19, 2026)
Arkeus | $18,000,000 | (May 19, 2026)
Shyld AI | $13,400,000 | (May 19, 2026)
Cimento AI | $3,000,000 | (May 19, 2026)
Cosmico | $12,000,000 | (May 19, 2026)
